A new antibiotic named terramycin, which had been laboriously isolated from a piece of Indiana soil, was announced early this year (TIME, Feb. 6) by Charles Pfizer & Co. of Brooklyn. Last week in Manhattan, at a clinicians' conference on terramycin, the accumulated evidence seemed to show that the new antibiotic has made the grade.
The only way to chart the effectiveness of a new drug is to test it on sick people under varying conditions. At the Manhattan meeting, doctors reported that terramycin was effective against some urinary tract infections, bacterial pneumonia, atypical pneumonia, undulant fever whooping cough and amoebic dysentery.'...
To continue reading:
or
Log-In
